Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal-Reference-Cited by-同舟云学术

Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Published:2017-06-27 Issue:12 Volume:35 Page:1211-1221
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Büyükkaramikli Nasuh C.,Blommestein Hedwig M.,Riemsma Rob,Armstrong Nigel,Clay Fiona. J.,Ross Janine,Worthy Gill,Severens Johan,Kleijnen Jos,Al Maiwenn J.

Funder

National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Program

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

http://link.springer.com/article/10.1007/s40273-017-0528-y/fulltext.html

Reference28 articles.

1. NICE. Guide to the single technology appraisal process, London, 2015. [Online]. https://www.nice.org.uk/process/pmg24/resources/single-technology-appraisal-user-guide-for-company-evidence-submission-template-pdf-72286715419333 . Accessed 08 Aug 2016.

2. NICE. Gastric cancer (metastatic)—ramucirumab (after chemotherapy) [ID741], NICE technology appraisal guidance [TA378], London, 2016. [Online]. https://www.nice.org.uk/guidance/indevelopment/gid-tag500 .Accessed 08 Aug 2016.

3. ONS. Cancer Registration Statistics, London, 2012. [Online]. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/2014-06-19#results . Accessed 06 June 2017.

4. Cancer Research UK. Stomach Cancer Incidence Statistics, Cancer Research UK, 2012. [Online]. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/stomach-cancer/incidence . Accessed 08 Aug 2016.

5. Cancer Research UK, Stomach Cancer Mortality Statistics. Cancer Research UK, 2012. [Online]. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/stomach-cancer/mortality . Accessed 08 Aug 2016.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness analysis of first-line sintilimab plus chemotherapy vs. chemotherapy alone for unresectable advanced or metastatic gastric or gastroesophageal junction cancer in China;Frontiers in Pharmacology;2024-09-04

2. Cost-effectiveness analysis of tislelizumab vs. camrelizumab for the treatment of second-line locally advanced or metastatic esophageal squamous cell carcinoma;BMC Health Services Research;2024-05-29

3. The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines;Frontiers in Oncology;2023-02-16

4. Cost-effectiveness analysis of sintilimab plus chemotherapy versus chemotherapy alone for the first-line treatment of advanced oesophageal squamous cell carcinoma;2022-10-20

5. Cost-Effectiveness of Nivolumab Plus Chemotherapy vs. Chemotherapy as First-Line Treatment for Advanced Gastric Cancer/Gastroesophageal Junction Cancer/Esophagel Adenocarcinoma in China;Frontiers in Oncology;2022-04-20